6-Methyl-2-oxo-4-propyl-1,2-dihydropyridine-3-carbonitrile

Catalog No. :
ACHBNF094
CAS No. :
16232-40-9
Molecular Formula :
C10H12N2O
Molecular Weight :
176.22

IUPAC Name:6-methyl-2-oxo-4-propyl-1,2-dihydropyridine-3-carbonitrile

6-Methyl-2-oxo-4-propyl-1,2-dihydropyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$105.00Login to see priceIn stockInquiry
500mg95%$176.00Login to see priceInquiryInquiry
1g95%$293.00Login to see priceInquiryInquiry
5g95%$883.00Login to see priceInquiryInquiry
10g95%$1052.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methyl-2-oxo-4-propyl-1,2-dihydropyridine-3-carbonitrile
IUPAC Name6-methyl-2-oxo-4-propyl-1,2-dihydropyridine-3-carbonitrile
MDL No.MFCD24387405
Molecular FormulaC10H12N2O
Molecular Weight176.22
SMILESN#CC1=C(CCC)C=C(C)NC1=O
InChI KeyXXEAVIQHEGQVSD-UHFFFAOYSA-N
Synonym16232-40-9 | 6-methyl-2-oxo-4-propyl-1,2-dihydropyridine-3-carbonitrile | 6-methyl-2-oxo-4-propyl-1H-pyridine-3-carbonitrile | 3-Pyridinecarbonitrile, 1,2-dihydro-6-methyl-2-oxo-4-propyl- | MFCD24387405 | SCHEMBL2586136 | DTXSID00576174 | XXEAVIQHEGQVSD-UHFFFAOYSA-N | 6-
CAS No.16232-40-9
PubChem CID15641801

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACHBNF094 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACROUF458 route compound structure diagram
    ACROUF458107-91-5 In Stock
  2. Then
  3. ACHBNF094 route product structure diagram
    ACHBNF09416232-40-9 In Stock
Inquiry

2. ACHBNF094 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHBNF094 route product structure diagram
    ACHBNF09416232-40-9 In Stock
Inquiry

Comments (0)